Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07210281Phase 4Recruiting

Osteogenon in Orthopedics and Traumatology

Role: lead

NCT06615518Not ApplicableActive Not Recruiting

Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in Patients With Lumbar Disc Herniation

Role: lead

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: collaborator

NCT06030661Unknown

The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%

Role: collaborator

NCT05487261Phase 4Unknown

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction

Role: collaborator

NCT05625607Recruiting

Polish Transcatheter Transfemoral Mitral Valve-in-Valve Implantation (Mitral ViV) Registry

Role: collaborator

All 6 trials loaded